Reference SummaryFenske TS, Cancer Res 2006 May 15;66(10):5029-38
Title |
Identification of candidate alkylator-induced cancer susceptibility genes by whole genome scanning in mice. |
Authors |
Fenske TS; McMahon C; Edwin D; Jarvis JC; Cheverud JM; Minn M; Mathews V; Bogue MA; Province MA; McLeod HL; Graubert TA |
Journal |
Cancer Res |
Volume |
66 |
Issue |
10 |
Year |
2006 |
Pages |
5029-38 |
Abstract |
Secondary malignancies are a serious adverse consequence of alkylator chemotherapy. The risk of developing an alkylator-associated malignancy is influenced by genetic background, although the relevant genetic factors are poorly understood. To screen for novel susceptibility factors, we established a mouse model of alkylator-induced malignancy. We exposed mice from 20 inbred strains to the prototypical alkylating agent, N-nitroso-N-ethylurea (ENU). ENU was a potent carcinogen in many of the strains tested, inducing 140 tumors in 240 ENU-treated mice (66% incidence of at least one tumor in evaluable mice), compared with a background incidence of 8% spontaneous tumors in 240 strain-, age-, and sex-matched control mice (relative risk, 8.4; P < 0.0001). A wide variety of tumor histologies were noted, including epithelial carcinomas, soft tissue sarcomas, and hematopoietic tumors. Cancer susceptibility was a heritable trait for the most common tumor types, lung adenocarcinoma (H(2) = 0.25), T cell lymphoma (H(2) = 0.19), and myeloid malignancies (H(2) = 0.10). Quantitative trait locus mapping identified regions on chromosomes 3, 6, 9, and 15 containing candidate genes associated with lung adenoma, lung carcinoma, and lymphoma susceptibility. This novel mouse model recapitulates many features of human alkylator-associated cancer and supports the hypothesis that susceptibility to this syndrome is influenced by inherited polymorphisms that could be used to make informed clinical treatment decisions. |
Links |
J:109061 – MGI References 16707424 – National Library of Medicine/PubMed |
Strain | Model Name | Treatment Agent(s) | Organ Affected | Frequency | Model Details |
---|---|---|---|---|---|
[not specified] | Adrenal gland - Medulla pheochromocytoma |
|
Adrenal gland - Medulla |
0.58 |
|
[not specified] | Blood vessel hemangioma |
|
Liver |
observed |
|
[not specified] | Blood vessel hemangioma | Liver |
0 |
||
[not specified] | Blood vessel hemangiosarcoma |
|
Blood vessel |
0.58 |
|
[not specified] | Connective tissue - Fibroblast fibroma |
|
Skin |
0.58 |
|
[not specified] | Connective tissue - Fibroblast fibroma | Skin |
0 |
||
[not specified] | Connective tissue - Fibroblast fibrosarcoma |
|
Connective tissue - Fibroblast |
observed |
|
[not specified] | Gastrointestinal tract adenoma |
|
Gastrointestinal tract |
observed |
|
[not specified] | Gastrointestinal tract adenoma | Gastrointestinal tract |
0 |
||
[not specified] | Gastrointestinal tract carcinoma |
|
Gastrointestinal tract |
observed |
|
[not specified] | Gastrointestinal tract carcinoma | Gastrointestinal tract |
0 |
||
CAST/EiJ | Gastrointestinal tract carcinoma |
|
Gastrointestinal tract |
observed |
|
A/J | Gastrointestinal tract carcinoma |
|
Gastrointestinal tract |
observed |
|
C57L/J | Gastrointestinal tract carcinoma |
|
Gastrointestinal tract |
observed |
|
SM/J | Gastrointestinal tract carcinoma |
|
Gastrointestinal tract |
observed |
|
[not specified] | Gastrointestinal tract tumor - epithelial |
|
Gastrointestinal tract |
observed |
|
[not specified] | Genital tract adenoma |
|
Genital tract |
observed |
|
[not specified] | Genital tract adenoma | Genital tract |
0 |
||
[not specified] | Genital tract carcinoma |
|
Genital tract |
observed |
|
[not specified] | Genital tract carcinoma | Genital tract |
0 |
||
[not specified] | Genital tract tumor - epithelial |
|
Genital tract |
observed |
|
[not specified] | Intestine - Large Intestine - Colon tumor - epithelial |
|
Intestine - Large Intestine - Colon |
observed |
|
[not specified] | Intestine - Large Intestine tumor - epithelial |
|
Intestine - Large Intestine |
observed |
|
[not specified] | Kidney tumor - epithelial |
|
Kidney |
observed |
|
[not specified] | Leukocyte - Lymphocyte - B-lymphocyte lymphoma |
|
Leukocyte - Lymphocyte - B-lymphocyte |
observed |
|
[not specified] | Leukocyte - Lymphocyte - T-lymphocyte lymphoma |
|
Leukocyte - Lymphocyte - T-lymphocyte |
observed |
|
[not specified] | Leukocyte - Lymphocyte lymphoma |
|
Leukocyte - Lymphocyte |
observed |
|
[not specified] | Leukocyte - Lymphocyte lymphoma | Leukocyte - Lymphocyte |
observed |
||
AKR/J | Leukocyte - Lymphocyte lymphoma |
|
Leukocyte - Lymphocyte |
15 - 100 |
|
C58/J | Leukocyte - Lymphocyte lymphoma |
|
Leukocyte - Lymphocyte |
66.67 - 70 |
|
C57BL/6J | Leukocyte - Lymphocyte lymphoma |
|
Leukocyte - Lymphocyte |
50 |
|
NOD/ShiLtJ | Leukocyte - Lymphocyte lymphoma |
|
Leukocyte - Lymphocyte |
50 |
|
FVB/NJ | Leukocyte - Lymphocyte lymphoma |
|
Leukocyte - Lymphocyte |
33.33 - 54 |
|
PL/J | Leukocyte - Lymphocyte lymphoma |
|
Leukocyte - Lymphocyte |
33.33 |
|
BALB/cByJ | Leukocyte - Lymphocyte lymphoma |
|
Leukocyte - Lymphocyte |
20 - 56 |
|
NZB/BlNJ | Leukocyte - Lymphocyte lymphoma |
|
Leukocyte - Lymphocyte |
20 |
|
DBA/2J | Leukocyte - Lymphocyte lymphoma |
|
Leukocyte - Lymphocyte |
16.67 |
|
SJL/J | Leukocyte - Lymphocyte lymphoma |
|
Leukocyte - Lymphocyte |
16.67 |
|
129S1/SvImJ | Leukocyte - Lymphocyte lymphoma |
|
Leukocyte - Lymphocyte |
12.5 |
|
C57L/J | Leukocyte - Lymphocyte lymphoma |
|
Leukocyte - Lymphocyte |
11.11 |
|
PERA/EiJ | Leukocyte - Lymphocyte lymphoma |
|
Leukocyte - Lymphocyte |
11.11 |
|
SM/J | Leukocyte - Lymphocyte lymphoma |
|
Leukocyte - Lymphocyte |
10 |
|
C3H/HeJ | Leukocyte - Lymphocyte lymphoma |
|
Leukocyte - Lymphocyte |
9.09 |
|
A/J | Leukocyte - Lymphocyte lymphoma |
|
Leukocyte - Lymphocyte |
0 |
|
CAST/EiJ | Leukocyte - Lymphocyte lymphoma |
|
Leukocyte - Lymphocyte |
0 |
|
MOLF/EiJ | Leukocyte - Lymphocyte lymphoma |
|
Leukocyte - Lymphocyte |
0 |
|
SPRET/EiJ | Leukocyte - Lymphocyte lymphoma |
|
Leukocyte - Lymphocyte |
0 |
|
SWR/J | Leukocyte - Lymphocyte lymphoma |
|
Leukocyte - Lymphocyte |
0 |
|
FVB/NJ | Leukocyte - Lymphocyte lymphoma | Leukocyte - Lymphocyte |
0 |
||
AKR/J | Leukocyte - Lymphocyte lymphoma | Leukocyte - Lymphocyte |
34 - 50 |
||
C58/J | Leukocyte - Lymphocyte lymphoma | Leukocyte - Lymphocyte |
0 |
||
BALB/cByJ | Leukocyte - Lymphocyte lymphoma | Leukocyte - Lymphocyte |
0 |
||
[not specified] | Leukocyte - Lymphocyte neoplasm |
|
Leukocyte - Lymphocyte |
observed |
|
[not specified] | Leukocyte - Monocyte - Macrophage - Histiocyte histiocytic sarcoma |
|
Leukocyte - Monocyte - Macrophage - Histiocyte |
0.58 |
|
[not specified] | Leukocyte - Monocyte - Macrophage - Histiocyte histiocytic sarcoma | Leukocyte - Monocyte - Macrophage - Histiocyte |
observed |
||
[not specified] | Leukocyte - Myelocyte (Granulocyte) dysplasia |
|
Leukocyte - Myelocyte (Granulocyte) |
observed |
|
[not specified] | Leukocyte - Myelocyte (Granulocyte) dysplasia | Leukocyte - Myelocyte (Granulocyte) |
0.52 |
||
[not specified] | Leukocyte - Myelocyte (Granulocyte) leukemia | Leukocyte - Myelocyte (Granulocyte) |
0.52 |
||
[not specified] | Leukocyte - Myelocyte (Granulocyte) leukemia - acute myeloid (AML) |
|
Leukocyte - Myelocyte (Granulocyte) |
observed |
|
[not specified] | Leukocyte - Myelocyte (Granulocyte) lymphoma |
|
Leukocyte - Myelocyte (Granulocyte) |
observed |
|
[not specified] | Leukocyte - Myelocyte (Granulocyte) sarcoma |
|
Leukocyte - Myelocyte (Granulocyte) |
observed |
|
[not specified] | Leukocyte - Myelocyte (Granulocyte) tumor - malignant |
|
Leukocyte - Myelocyte (Granulocyte) |
observed |
|
SWR/J | Leukocyte - Myelocyte (Granulocyte) tumor - malignant |
|
Leukocyte - Myelocyte (Granulocyte) |
80 |
|
DBA/2J | Leukocyte - Myelocyte (Granulocyte) tumor - malignant |
|
Leukocyte - Myelocyte (Granulocyte) |
50 |
|
BALB/cByJ | Leukocyte - Myelocyte (Granulocyte) tumor - malignant |
|
Leukocyte - Myelocyte (Granulocyte) |
33.33 |
|
NOD/ShiLtJ | Leukocyte - Myelocyte (Granulocyte) tumor - malignant |
|
Leukocyte - Myelocyte (Granulocyte) |
25 |
|
AKR/J | Leukocyte - Myelocyte (Granulocyte) tumor - malignant |
|
Leukocyte - Myelocyte (Granulocyte) |
20 |
|
PL/J | Leukocyte - Myelocyte (Granulocyte) tumor - malignant |
|
Leukocyte - Myelocyte (Granulocyte) |
16.67 |
|
129S1/SvImJ | Leukocyte - Myelocyte (Granulocyte) tumor - malignant |
|
Leukocyte - Myelocyte (Granulocyte) |
0 |
|
A/J | Leukocyte - Myelocyte (Granulocyte) tumor - malignant |
|
Leukocyte - Myelocyte (Granulocyte) |
0 |
|
C3H/HeJ | Leukocyte - Myelocyte (Granulocyte) tumor - malignant |
|
Leukocyte - Myelocyte (Granulocyte) |
0 |
|
C57BL/6J | Leukocyte - Myelocyte (Granulocyte) tumor - malignant |
|
Leukocyte - Myelocyte (Granulocyte) |
0 |
|
C57L/J | Leukocyte - Myelocyte (Granulocyte) tumor - malignant |
|
Leukocyte - Myelocyte (Granulocyte) |
0 |
|
C58/J | Leukocyte - Myelocyte (Granulocyte) tumor - malignant |
|
Leukocyte - Myelocyte (Granulocyte) |
0 |
|
CAST/EiJ | Leukocyte - Myelocyte (Granulocyte) tumor - malignant |
|
Leukocyte - Myelocyte (Granulocyte) |
0 |
|
FVB/NJ | Leukocyte - Myelocyte (Granulocyte) tumor - malignant |
|
Leukocyte - Myelocyte (Granulocyte) |
0 |
|
MOLF/EiJ | Leukocyte - Myelocyte (Granulocyte) tumor - malignant |
|
Leukocyte - Myelocyte (Granulocyte) |
0 |
|
NZB/BlNJ | Leukocyte - Myelocyte (Granulocyte) tumor - malignant |
|
Leukocyte - Myelocyte (Granulocyte) |
0 |
|
PERA/EiJ | Leukocyte - Myelocyte (Granulocyte) tumor - malignant |
|
Leukocyte - Myelocyte (Granulocyte) |
0 |
|
SJL/J | Leukocyte - Myelocyte (Granulocyte) tumor - malignant |
|
Leukocyte - Myelocyte (Granulocyte) |
0 |
|
SM/J | Leukocyte - Myelocyte (Granulocyte) tumor - malignant |
|
Leukocyte - Myelocyte (Granulocyte) |
0 |
|
SPRET/EiJ | Leukocyte - Myelocyte (Granulocyte) tumor - malignant |
|
Leukocyte - Myelocyte (Granulocyte) |
0 |
|
[not specified] | Liver adenoma |
|
Liver |
observed |
|
[not specified] | Liver adenoma | Liver |
0 |
||
[not specified] | Liver carcinoma |
|
Liver |
observed |
|
[not specified] | Liver carcinoma | Liver |
0 |
||
[not specified] | Lung adenocarcinoma |
|
Lung |
observed |
|
[not specified] | Lung adenocarcinoma | Lung |
0.52 |
||
[not specified] | Lung adenoma |
|
Lung |
observed |
|
[not specified] | Lung adenoma | Lung |
observed |
||
SM/J | Lung adenoma |
|
Lung |
observed |
|
129S1/SvImJ | Lung adenoma |
|
Lung |
observed |
|
C3H/HeJ | Lung adenoma |
|
Lung |
observed |
|
[not specified] | Lung carcinoma |
|
Lung |
observed |
|
A/J | Lung carcinoma |
|
Lung |
75 - 86 |
|
PERA/EiJ | Lung carcinoma |
|
Lung |
66.67 - 85.5 |
|
SWR/J | Lung carcinoma |
|
Lung |
60 |
|
FVB/NJ | Lung carcinoma |
|
Lung |
33 - 100 |
|
BALB/cByJ | Lung carcinoma |
|
Lung |
20 |
|
DBA/2J | Lung carcinoma |
|
Lung |
16.67 |
|
MOLF/EiJ | Lung carcinoma |
|
Lung |
14.29 |
|
NOD/ShiLtJ | Lung carcinoma |
|
Lung |
12.5 |
|
129S1/SvImJ | Lung carcinoma |
|
Lung |
12.5 |
|
SPRET/EiJ | Lung carcinoma |
|
Lung |
9.09 |
|
SJL/J | Lung carcinoma |
|
Lung |
0 |
|
PL/J | Lung carcinoma |
|
Lung |
0 |
|
NZB/BlNJ | Lung carcinoma |
|
Lung |
0 |
|
CAST/EiJ | Lung carcinoma |
|
Lung |
0 |
|
C58/J | Lung carcinoma |
|
Lung |
0 |
|
C57L/J | Lung carcinoma |
|
Lung |
0 |
|
C57BL/6J | Lung carcinoma |
|
Lung |
0 |
|
C3H/HeJ | Lung carcinoma |
|
Lung |
0 |
|
AKR/J | Lung carcinoma |
|
Lung |
0 |
|
SM/J | Lung carcinoma |
|
Lung |
0 |
|
FVB/NJ | Lung carcinoma | Lung |
0 |
||
A/J | Lung carcinoma | Lung |
0 |
||
PERA/EiJ | Lung carcinoma | Lung |
0 |
||
[not specified] | Lung carcinoma - acinar |
|
Lung |
observed |
|
[not specified] | Lung tumor - benign |
|
Lung |
observed |
|
[not specified] | Lung tumor - benign | Lung |
observed |
||
[not specified] | Lung tumor - malignant |
|
Lung |
observed |
|
[not specified] | Lung tumor - malignant | Lung |
observed |
||
[not specified] | Mammary gland carcinoma |
|
Mammary gland |
0.58 |
|
[not specified] | Mammary gland carcinoma | Mammary gland |
0 |
||
[not specified] | Mesodermal cell/mesoblast sarcoma |
|
Lymph node |
observed |
|
[not specified] | Mesodermal cell/mesoblast sarcoma |
|
Mediastinum |
observed |
|
[not specified] | Mesodermal cell/mesoblast sarcoma |
|
Mesodermal cell/mesoblast |
observed |
|
[not specified] | Mesodermal cell/mesoblast sarcoma | Mesodermal cell/mesoblast |
observed |
||
[not specified] | Muscle - Striated - Skeletal rhabdomyosarcoma |
|
Muscle - Striated - Skeletal |
0.58 |
|
[not specified] | Ovary tumor - epithelial |
|
Ovary |
observed |
|
[not specified] | PNS - Schwann cell schwannoma |
|
PNS - Schwann cell |
0.58 |
|
[not specified] | Stomach tumor - epithelial |
|
Stomach |
observed |
|
[not specified] | Uterus tumor - epithelial |
|
Uterus |
observed |
|
[not specified] | (Unspecified organ) tumor |
|
(Unspecified organ) |
observed |
|
[not specified] | (Unspecified organ) tumor | (Unspecified organ) |
observed |